Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin and mortality in COVID-19: a systematic review and meta-analysis of pooled adjusted effect estimates from propensity-matched cohorts
Ahmad Fariz Malvi Zamzam Zein, Catur Setiya Sulistiyana, Uswatun Khasanah, et al.
Postgraduate Medical Journal (2021) Vol. 98, Iss. 1161, pp. 503-508
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Simvastatin in Critically Ill Patients with Covid-19
Thomas Hills, Elizabeth Lorenzi, Lindsay R. Berry, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 25, pp. 2341-2354
Open Access | Times Cited: 32
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
Stanisław Surma, Maciej Banach, Joanna Lewek
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Effect of Statins on All-Cause Mortality in Adults: A Systematic Review and Meta-Analysis of Propensity Score-Matched Studies
M. Nowak, Mariusz Niemczyk, Michał Florczyk, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5643-5643
Open Access | Times Cited: 23
Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review
Carles Vilaplana-Carnerero, Maria Giner‐Soriano, Ángela Domı́nguez, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1206-1206
Open Access | Times Cited: 14
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Ut-Sam Lao, Chak-Fun Law, Daniel T. Baptista‐Hon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5454-5454
Open Access | Times Cited: 19
Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19 — A systematic review and meta-analysis
Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
Primary care diabetes (2021) Vol. 16, Iss. 1, pp. 162-167
Open Access | Times Cited: 21
Effect of colchicine on mortality in patients with COVID-19 – A systematic review and meta-analysis
Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 2, pp. 102395-102395
Open Access | Times Cited: 12
Prior Statin vs In-Hospital Statin Usage in Severe COVID-19: Review and Meta-Analysis
Iad Alhallak, Hakan Paydak, Jawahar L. Mehta
Current Problems in Cardiology (2023) Vol. 48, Iss. 9, pp. 101810-101810
Open Access | Times Cited: 6
Association of statin use with outcomes of patients admitted with COVID-19: an analysis of electronic health records using superlearner
Adovich S. Rivera, Omar Al-Heeti, Lucia C. Petito, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Lipid compartments and lipid metabolism as therapeutic targets against coronavirus
Daniella Cesar-Silva, Filipe S. Pereira‐Dutra, Ana L.M. Giannini, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Therapeutics in hospitalised adult patients with COVID-19
Nicolás Roche, James D. Chalmers
European Respiratory Society eBooks (2024)
Closed Access | Times Cited: 1
EXPRESS: Short-term Efficacy of Moderate Intensity Rosuvastatin in COVID-19 Patients: A Randomized Clinical Trial
Katayoun Rafsanjani, Amirhossein Ghaseminejad‐Raeini, Alireza Azarboo, et al.
Journal of Investigative Medicine (2024) Vol. 73, Iss. 1, pp. 85-93
Closed Access | Times Cited: 1
Association of early statin initiation during COVID-19 admission with inpatient mortality at an academic health system in Illinois, March 2020 to September 2022: a target trial emulation using observational data
Adovich S. Rivera, Omar Al-Heeti, Matthew J. Feinstein, et al.
BMJ Open (2024) Vol. 14, Iss. 10, pp. e085547-e085547
Open Access | Times Cited: 1
In Vitro Evidence of Statins’ Protective Role against COVID-19 Hallmarks
Donatella Fiore, Maria Proto, Silvia Franceschelli, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2123-2123
Open Access | Times Cited: 8
The Association between Dyslipidemia and Pulmonary Diseases
Hideaki Isago
Journal of Atherosclerosis and Thrombosis (2024) Vol. 31, Iss. 9, pp. 1249-1259
Open Access | Times Cited: 1
Association of antecedent statin use on 30-day, 60-day and 90-day mortality among Mississippi Medicaid beneficiaries diagnosed with COVID-19
Yiran Rong, Swarnali Goswami, O Eriakha, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e076195-e076195
Open Access | Times Cited: 3
Identification of subgroups within a Japanese older adult population for whom statin therapy is effective in reducing mortality
Daito Funaki, Hideaki Kaneda, Akinori Miyakoshi, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0295052-e0295052
Open Access | Times Cited: 2
Postrecovery COVID-19 and interlinking diabetes and cardiovascular events
Giuseppe Seghieri
Elsevier eBooks (2024), pp. 377-382
Closed Access
Statins for the treatment of COVID-19 patients: an updated meta-analysis of randomized controlled trials
Fatemeh Movahed, Ehsan Heidari, Masoud Dehbozorgi, et al.
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Potential role of geranylgeraniol in managing statin-associated muscle symptoms: a COVID-19 related perspective
Barrie Tan, Kok‐Yong Chin
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 1
Long-Term Major Adverse Cardiovascular Events in Patients with Moderate and Severe COVID-19: A Focus on Early Statin Use and Previous CVD
Arezoo Khosravi, Saeed Ghodsi, Mohammadreza Memarjafari, et al.
The Journal of Tehran University Heart Center (2023)
Open Access | Times Cited: 1
"Repurposed Nystatin to Inhibit SARS-Cov-2 and Mutants in the GI Tract"
Eszter Virág
Biomedical Journal of Scientific & Technical Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 3
Survival impact of previous statin therapy in patients hospitalized with COVID-19
Eduardo Barge‐Caballero, Pedro J. Marcos-Rodríguez, Nieves Domenech-García, et al.
Medicina Clínica (English Edition) (2022) Vol. 160, Iss. 1, pp. 1-9
Open Access | Times Cited: 2
Impacto del tratamiento previo con estatinas sobre la supervivencia de los pacientes hospitalizados con COVID-19
Eduardo Barge‐Caballero, Pedro J. Marcos-Rodríguez, Nieves Domenech-García, et al.
Medicina Clínica (2022) Vol. 160, Iss. 1, pp. 1-9
Open Access | Times Cited: 1
Statins and COVID-19 (Mechanism of Action, Effect on Prognosis)
Joanna Lewek, Stanisław Surma, Maciej Banach
Contemporary cardiology (2022), pp. 285-302
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top